Skip to main content

Radiotherapy for Dermatofibrosarcoma Protuberans

  • Chapter
  • First Online:
Radiation Therapy for Skin Cancer
  • 2185 Accesses

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare indolent cutaneous tumor; approximately 10–15 % contain areas of fibrosarcoma (DFSP-FS) and tend to behave more aggressively. The optimal treatment is resection with wide margins; the likelihood of local control after this procedure exceeds 90 %. Patients with positive or close margins have a high risk of local recurrence after surgery alone; the addition of postoperative radiotherapy results in local control rates of 85 % or higher. The dose-fractionation schedules are similar to those used for carcinomas. Experience with radiotherapy alone for gross disease is limited. The probability of regional or distant metastases is 5 % or less.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Suit H, Spiro I, Mankin HJ, Efird J, Rosenberg AE. Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol. 1996;14(8):2365–9.

    PubMed  CAS  Google Scholar 

  2. Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol. 2004;30(3):341–5.

    Article  PubMed  CAS  Google Scholar 

  3. Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88(12):2711–20.

    Article  PubMed  CAS  Google Scholar 

  4. Lindner NJ, Scarborough MT, Powell GJ, Spanier S, Enneking WF. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol. 1999;25(4):392–7.

    Article  PubMed  CAS  Google Scholar 

  5. Enzinger FM, Weiss SW. Fibrohistiocytic tumors of intermediate malignancy. In: Stamatis G, editor. Soft tissue tumors. St. Louis, MO: Mosby; 1988. p. 252–68.

    Google Scholar 

  6. Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992;18(3):241–8.

    PubMed  CAS  Google Scholar 

  7. McArthur G. Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin Oncol. 2004;31(2 Suppl 6):30–6.

    Article  PubMed  CAS  Google Scholar 

  8. Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J, Kere J, Miettinen M, Knuutila S. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet. 2001;92(3–4):192–5.

    Article  PubMed  CAS  Google Scholar 

  9. Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol. 2003;163(6):2383–95.

    Article  PubMed  CAS  Google Scholar 

  10. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140(1):1–12.

    Article  PubMed  CAS  Google Scholar 

  11. Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, et al. Dermatofibrosarcoma protuberans: treatment results of 35 cases. Radiother Oncol. 2000;57(2):175–81.

    Article  PubMed  CAS  Google Scholar 

  12. Gayner SM, Lewis JE, McCaffrey TV. Effect of resection margins on dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol Head Neck Surg. 1997;123(4):430–3.

    Article  PubMed  CAS  Google Scholar 

  13. Stojadinovic A, Karpoff HM, Antonescu CR, Shah JP, Singh B, Spiro RH, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol. 2000;7(9):696–704.

    Article  PubMed  CAS  Google Scholar 

  14. Goldblum JR, Reith JD, Weiss SW. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol. 2000;24(8):1125–30.

    Article  PubMed  CAS  Google Scholar 

  15. Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, Kobayashi C, et al. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans. Hum Pathol. 2004;35(2):240–5.

    Article  PubMed  CAS  Google Scholar 

  16. Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumors. 4th ed. Philadelphia, PA: Mosby; 2001.

    Google Scholar 

  17. Sasaki M, Ishida T, Horiuchi H, MacHinami R. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression. Pathol Int. 1999;49(9):799–806.

    Article  PubMed  CAS  Google Scholar 

  18. Torreggiani WC, Al-Ismail K, Munk PL, Nicolaou S, O’Connell JX, Knowling MA. Dermatofibrosarcoma protuberans: MR imaging features. AJR Am J Roentgenol. 2002;178(4):989–93.

    Article  PubMed  Google Scholar 

  19. Domanski HA, Gustafson P. Cytologic features of primary, recurrent, and metastatic dermatofibrosarcoma protuberans. Cancer. 2002;96(6):351–61.

    Article  PubMed  Google Scholar 

  20. Klijanienko J, Caillaud JM, Lagace R. Fine-needle aspiration of primary and recurrent dermatofibrosarcoma protuberans. Diagn Cytopathol. 2004;30(4):261–5.

    Article  PubMed  Google Scholar 

  21. Calikoglu E, Augsburger E, Chavaz P, Saurat JH, Kaya G. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol. 2003;30(3):185–9.

    Article  PubMed  Google Scholar 

  22. Fanburg-Smith JC, Miettinen M. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol. 2001;32(9):976–83.

    Article  PubMed  CAS  Google Scholar 

  23. Enneking WF, Spanier SS, Goodman MA. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg Am. 1980;62(6):1027–30.

    PubMed  CAS  Google Scholar 

  24. Parsons JT, Zlotecki RA, Reddy KA, Mitchell TP, Marcus RB, Jr, Scarborough MT. The role of radiotherapy and limb-conserving surgery in the management of soft-tissue sarcomas in adults. Hematol Oncol Clin North Am. 2001;15(2):377–88, vii.

    Google Scholar 

  25. AJCC. Soft tissue sarcoma. In: Green FL, editor. AJCC cancer staging manual. New York, NY: Springer; 2002. p. 193–200.

    Google Scholar 

  26. Khatri VP, Galante JM, Bold RJ, Schneider PD, Ramsamooj R, Goodnight Jr JE. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol. 2003;10(9):1118–22.

    Article  PubMed  Google Scholar 

  27. Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 2004;101(1):28–38.

    Article  PubMed  Google Scholar 

  28. Wacker J, Khan-Durani B, Hartschuh W. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol. 2004;11(4):438–44.

    Article  PubMed  Google Scholar 

  29. DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer. 2004;100(5):1008–16.

    Article  PubMed  Google Scholar 

  30. Nouri K, Lodha R, Jimenez G, Robins P. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience. Dermatol Surg. 2002;28(11):1060–4; discussion 4.

    Google Scholar 

  31. Ballo MT, Zagars GK, Pisters P, Pollack A. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998;40(4):823–7.

    Article  PubMed  CAS  Google Scholar 

  32. Cai H, Wang Y, Wu J, Shi Y. Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China. J Surg Oncol. 2012;105(2):142–8.

    Article  PubMed  Google Scholar 

  33. Dagan R, Morris CG, Zlotecki RA, Scarborough MT, Mendenhall WM. Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol. 2005;28(6):537–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William M. Mendenhall .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mendenhall, W.M. (2013). Radiotherapy for Dermatofibrosarcoma Protuberans. In: Cognetta Jr., A., Mendenhall, W. (eds) Radiation Therapy for Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6986-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6986-5_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6985-8

  • Online ISBN: 978-1-4614-6986-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics